Merck & Co Inc (MRK)
101.87
-0.01
(-0.01%)
USD |
NYSE |
Nov 04, 16:00
101.75
-0.12
(-0.12%)
Pre-Market: 06:42
Merck Cash from Investing (Quarterly): -1.069B for June 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -1.069B |
| March 31, 2024 | -1.376B |
| December 31, 2023 | 53.00M |
| September 30, 2023 | -334.00M |
| June 30, 2023 | -11.44B |
| March 31, 2023 | -2.359B |
| December 31, 2022 | -1.748B |
| September 30, 2022 | -962.00M |
| June 30, 2022 | -1.077B |
| March 31, 2022 | -1.173B |
| December 31, 2021 | -12.05B |
| September 30, 2021 | -1.061B |
| June 30, 2021 | -2.707B |
| March 31, 2021 | -738.00M |
| December 31, 2020 | -4.778B |
| September 30, 2020 | -2.155B |
| June 30, 2020 | -882.00M |
| March 31, 2020 | -1.628B |
| December 31, 2019 | -763.00M |
| September 30, 2019 | 191.00M |
| June 30, 2019 | -2.425B |
| March 31, 2019 | 368.00M |
| December 31, 2018 | 2.178B |
| September 30, 2018 | 1.66B |
| June 30, 2018 | 673.00M |
| Date | Value |
|---|---|
| March 31, 2018 | -197.00M |
| December 31, 2017 | -58.00M |
| September 30, 2017 | 671.00M |
| June 30, 2017 | -1.127B |
| March 31, 2017 | 3.193B |
| December 31, 2016 | -2.563B |
| September 30, 2016 | -890.00M |
| June 30, 2016 | -1.498B |
| March 31, 2016 | 1.741B |
| December 31, 2015 | -617.00M |
| September 30, 2015 | -61.00M |
| June 30, 2015 | 2.525B |
| March 31, 2015 | -6.605B |
| December 31, 2014 | 7.204B |
| September 30, 2014 | -3.722B |
| June 30, 2014 | -49.00M |
| March 31, 2014 | -3.807B |
| December 31, 2013 | 1.177B |
| September 30, 2013 | -2.037B |
| June 30, 2013 | -1.135B |
| March 31, 2013 | -1.153B |
| December 31, 2012 | -4.398B |
| September 30, 2012 | -1.839B |
| June 30, 2012 | -298.00M |
| March 31, 2012 | -270.00M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-12.05B
Minimum
Dec 2021
53.00M
Maximum
Dec 2023
-2.539B
Average
-1.173B
Median
Mar 2022
Cash from Investing (Quarterly) Benchmarks
| Amgen Inc | -210.00M |
| Johnson & Johnson | -3.128B |
| Eli Lilly and Co | -4.005B |
| Pfizer Inc | 4.60B |
| Moderna Inc | 1.649B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 5.637B |
| Cash from Financing (Quarterly) | 1.216B |
| Free Cash Flow | 13.15B |
| Free Cash Flow Per Share (Quarterly) | 1.905 |
| Free Cash Flow to Equity (Quarterly) | 1.277B |
| Free Cash Flow to Firm (Quarterly) | 5.065B |
| Free Cash Flow Yield | 5.08% |